Effectiveness of Multidisciplinary Approach on Quality of Life and Drug Related Problems in Diabetes Mellitus and/or Hypertensive Patients Diagnosed with Chronic Kidney Disease
Article Sidebar
Main Article Content
Abstract
Objective: To evaluate health-related quality of life (QOL) and drug related problems (DRPs) in patients receiving care from a multidisciplinary chronic kidney disease (CKD) clinic with pharmacist providing counseling on drugs and self-management to control risk factors and identifying DRPs. Method: First part of the study was a prospective descriptive study to investigate DRPs and QOL among patients before receiving treatment from the CKD clinic. Second part of the study was a quasi-experimental study to evaluate QOL changes among patients receiving care from the multidisciplinary CKD clinic. Primary outcomes in the study were DRPs and QOL as measured by the EQ-5D-5L. Results: The study included 234 CKD patients with an average age of 64.53±10.12 years. The most common comorbidity was hypertension. A total of 134 DRPs in CKD patients stage 1-2 were identified, with taking fewer medications than prescribed by physicians or missed doses as the most common one (77.61%). The identified DRPs were addressed and managed mainly at the patients by drug counseling. Most recommendations for resolving DRPs were accepted and followed. The outcomes were most DRPs being resolved. Average utility score of CKD patients before participating in the study was 0.9526±0.0617. At month 3, utility score of CKD patients in stages 1-2 and 3b-3b significantly increased (P=0.044 and <0.001, respectively). At month 6, utility score of CKD patients in stages 4-5 significantly increased (P=0.005). Conclusion: The provision of care and advices for CKD patients by pharmacists, in collaboration with a multidisciplinary healthcare team, could resolve DRPs and significantly improve utility score among patients with stage 3-5 kidney disease.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
ผลการวิจัยและความคิดเห็นที่ปรากฏในบทความถือเป็นความคิดเห็นและอยู่ในความรับผิดชอบของผู้นิพนธ์ มิใช่ความเห็นหรือความรับผิดชอบของกองบรรณาธิการ หรือคณะเภสัชศาสตร์ มหาวิทยาลัยสงขลานครินทร์ ทั้งนี้ไม่รวมความผิดพลาดอันเกิดจากการพิมพ์ บทความที่ได้รับการเผยแพร่โดยวารสารเภสัชกรรมไทยถือเป็นสิทธิ์ของวารสารฯ
References
Yeesunkaew R, Na Nongkhai Y, Shayakul C, Sujira rat D. Quality of life in end state renal receiving hemodialysis according to the different health benefit schemes: A private hospital case study. Vajira Nursing Journal. 2018; 18: 79–88.
Eknoyan G, Lameire N, Eckardt KU. Clinical practice guideline for the evaluation and management of chronic kidney disease KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013; 3: 1470–3.
Thanakitjaru P. Current situation of chronic kidney disease in Thailand. Journal of the Department of Medical Services. 2015; 40: 5–17.
Ingsathit A, Thakkinstian A, Chaiprasert A, Sangtha wan P, Gojaseni P, Kiattisunthorn K, et al. Preva- lence and risk factors of chronic kidney disease in the Thai adult population: Thai SEEK study. Nephrol Dial Transplant. 2010; 25: 1567–75.
Cha’on U, Tippayawat P, Sae-ung N, Pinlaor P, Siri thanaphol W, Theeranut A, et al. High prevalence of chronic kidney disease and its related risk factors in rural areas of Northeast Thailand. Sci Rep. 2022 28; 12: 18188. doi.org/10.1038/s41598-022-22538-w
Steinman MA, Miao Y, Boscardin WJ, Komaiko KDR, Schwartz JB. Prescribing quality in older veterans: a multifocal approach. J Gen Intern Med. 2014; 29: 1379–86.
Phromkamdang K, Sirilak T. Effects of pharmaceuti- cal care on clinical outcomes in patients with chronic kidney disease in Wiang Haeng Hospital, Chiang Mai province. Journal of Nursing and Public Health Research. 2023; 3: 1–19.
Sawatpanich J. Primary pharmaceutical care services among patients with chronic kidney disease Kantharawichai Hospital, Mahasarakham province. Research and Development Health System Journal 2014; 7: 57–63.
Chaiyasung P, Jukchai P, Sridet R, Nanudorn A. The development of self-care promotion program on behavior self-care of chronic disease patients with chronic kidney disease at home. Journal of Nursing and Education. 2020;13: 27–42.
Rattanachotphanit T, Waleekhachonloet O, Chana sopon S, Ausornsagiam W, Kanjanasilp J, Suwatta nasilp A, et al. Quality of life and utilities of end stage renal disease patients undergoing dialysis. Isan Journal of Pharmaceutical Sciences. 2018; 14: 88–98.
Yeesunkaew R, Na Nongkhai S, Chayakul C, Sujira rat D. Assessment quality of life in end stage renal disease patients undergoing hemodialysis. Vajira Nursing Journal. 2016; 18: 79–88.
Sutthi C, Sutthi W. Utility and cost assessment of patients with chronic kidney disease stages 3 to 5 at a General hospital. [Independent study]: Mahasara- kham University; 2018.
Chen SH, Tsai YF, Sun CY, Wu IW, Lee CC, Wu MS. The impact of self-management support on the progression of chronic kidney disease--a prospective randomized controlled trial. Nephrol Dial Transplant. 2011; 26: 3560–6.
Pharmaceutical Care Network Europe Foundation. PCNE classification for drug related problems V 8.02 [online]. 2017 [cited Mar 30, 2023]. Available from: www.pcne.org/upload/files/230_PCNE_classification_V8-02.pdf.
Pattanamongkol O, Chantaracha D, Chalongsuk R, Pongchaidecha M, Rungprai D, Muongmee S. The cost-effectiveness of pharmaceutical care to slow progression of the kidney in chronic kidney disease with diabetes patients at Laem Chabang hospital, Chonburi province. Thai Bulletin of Pharmaceutical Sciences. 2018; 13: 53–67.
Srisubat A, Jiamjariyaporn T, Chanpitakkul M, Lees midt V, Wisansak W, Promnim S. Cost-effectiveness of integrated care in patients with chronic kidney disease stage 3 and 4 compared with standard care in rural communities. Journal of the Department of Medical Services. 2017; 42: 54–63.
Ali B, Gray-Vickrey P. Limiting the damage from acute kidney injury. Nursing (Brux). 2011; 41: 22–31
Champati S. Causes of patient’s medication problems and interventions in home care visits by pharmacists. Thai Journal of Clinical Pharmacy 2017; 23: 1-9
Steinman MA, Miao Y, Boscardin WJ, Komaiko KDR, Schwartz JB. Prescribing quality in older veterans: a multifocal approach. J Gen Intern Med 2014; 29: 1379–86.
Narvekar RS, Bhandare NN, Gouveia JJ, Bhandare PN. Utilization pattern of potentially inappropriate medications in geriatric patients in a tertiary care hospital: a retrospective observational study. J Clin Diagn Res. 2017 11: FC04–8.
Via-Sosa MA, Lopes N, March M. Effectiveness of a drug dosing service provided by community pharmacists in polymedicated elderly patients with renal impairment--a comparative study. BMC Fam Pract. 2013; 14: 96. doi.org/10.1186/1471-2296-14-96.
Hoffmann F, Boeschen D, Dörks M, Herget-Rosen thal S, Petersen J, Schmiemann G. Renal insuffi- ciency and medication in nursing home residents. a cross-sectional study (IMREN). Dtsch Arztebl Int. 2016; 113: 92–8.
Chang F, O’Hare AM, Miao Y, Steinman MA. Use of renally inappropriate medications in older veterans: a national study. J Am Geriatr Soc. 2015; 63: 2290–7.
Breton G, Froissart M, Janus N, Launay-Vacher V, Berr C, Tzourio C, et al. Inappropriate drug use and mortality in community-dwelling elderly with impaired kidney function--the Three-City population-based study. Nephrol Dial Transplant. 2011; 26: 2852–9.
Papaioannou A, Clarke JA, Campbell G, Bédard M. Assessment of adherence to renal dosing guidelines in long-term care facilities. J Am Geriatr Soc. 2000; 48: 1470–3.
Chanpitakkul M. The effect of integrated care on the health related quality of life in CKD patients: a community hospital approach. In: Tangsanga K, editor. Workshop on “The development of a care model for patients with chronic kidney disease by a multidisciplinary team of the district hospital and by a community nurse of the Tambon Health Promoting Hospital” Bhumirajanagarindra Kidney Institute; 2019 . p. 41–9.
